Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-06-17T13:09:52.440Z Has data issue: false hasContentIssue false
  • English
  • Français

Antibiotic Resistance in ICUs: A Multifaceted Problem Requiring a Multifaceted Solution

Published online by Cambridge University Press:  02 January 2015

Robert Gaynes
Robert Gaynes*
Affiliation:
Hospital Infections Program, National Centerfor Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Chief Nosocomial Infections Surveillance Activity, Hospital Infections Program, Mailstop E55, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Infection Control & Hospital Epidemiology , Volume 16 , Issue 6 , June 1995 , pp. 328 - 330
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1995

References

1. Levy, SE. The Antibiotic Paradox. How Miracle Drugs Are Destroying the Miracle. New York, NY: Plenum Press; 1992.Google Scholar
2. Bryan, RT, Pinner, RW, Gaynes, RP Peters, CJ, Aguilar, JR, Berkelman, RL. Addressing emerging infectious disease threats: a prevention strategy for the United States. MMWR 1994;43(RR-5):1–18.Google Scholar
3. Tomasz, A. Multiple antibiotic resistant pathogenic bacteria. A report on the Rockefeller University workshop. N. Eng J Med 1994;330:1247–1251.Google Scholar
4. Billstein, SA. How the pharmaceutical industry brings an antibiotic drug to market in the United States. Antimicrob Agents Chmother 1994;38:2679–2682.Google Scholar
5. Coronado, VG. Edwards, JR, Culver, DH. Gaynes RP National Nosocomial Infections Surveillance system. Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol 1995;16;71–75.CrossRefGoogle ScholarPubMed
6. Blumberg, HM, Rimland, D, Carroll, DJ, Terry, FP Wachsmuth, IK. Rapid development of ciprofloxacin resistance in methicillin-susceptible and resistant Staphylococcus aureus . J Infect Dis 1991;163:1279–1285.Google Scholar
7. Bryce, EA, Smith, JA Focused microbiological surveillance and gram-negative β-lactamase-mediated resistance in an intensive care unit. Infect Control Hosp Epidemiol 1995;16:331–334.CrossRefGoogle Scholar
8. Yu, VL, Oakes, CA, Axnick, KJ, Merigan, TC. Patient factors contributing to the emergence of gentamicin-resistant Serratia marcescens . Am J Med 1979;44:468–473.Google Scholar
9. Weinstein, RA, Kabins, SA. Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med 1981;70:449–452.CrossRefGoogle ScholarPubMed
10. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR 1993;42:597–599.Google Scholar
11. Burwen, DR, Banerjee, SN, Gaynes, RP National Nosocomial Infections Surveillance system. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States J Infect Dis 1994;170:1622–1625.CrossRefGoogle ScholarPubMed
12. Gaynes, R, Culver, D, National Nosocomial Infections Surveillance (NNIS) system. Resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemio1 1991;13:1014.Google Scholar
13. Weinstein, RA, Nathan, C, Gruensfelder, R, Kabins, SA. Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms. J Infect Dis 1980;141:338–342.Google Scholar
14. Centers for Disease Control and Prevention. Nosocomial infection rates for interhospital comparison: limitations and possible solutions. Infect Control Hosp Epidemiol 1991;12:609–621.CrossRefGoogle Scholar
15. McGowan, JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15:478–483.Google Scholar
16. Kritchevsky, SB, Simmons, BP Toward better antibiotic use in hospitals. Infect Control Hosp Epidemiol 1994;15:68&690.Google Scholar
17. McGowan, JE. Antibiotic-resistant bacteria and healthcare systems: four steps for effective response. Infect Control Hosp Epidemiol 1995;16:67–70.CrossRefGoogle ScholarPubMed
18. HICPAC. Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105113.Google Scholar
19. Pallares, R, Dick, R, Wenzel, RP Adams, JR, Nettleman, MD. Trends in antimicrobial utilization at a tertiary teaching hospital during a 15-year period (19781992). Infect Control Hosp Epidemiol 1993;14:37&382.Google Scholar
20. Ballow, CH, Schentag, JJ. Trends in antibiotic utilization and bacterial resistance. Diagn Microbial Infect Dis 1992;15:37S–42S.CrossRefGoogle ScholarPubMed
21. Evans, RS, Larsen, RA, Burke, JP, et al. Computer surveillance of hospital-acquired infections and antibiotic use. JAMA 1986;256:1007–1011.Google Scholar